Steven Cohen’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.7M Buy
212,971
+152,695
+253% +$30.3M 0.05% 511
2026
Q2
$11.3M Buy
+60,276
New +$8.8M 0.01% 1206
2026
Q1
– Sell
-446,616
Closed -$45.1M – 4400
2025
Q4
$35.6M Buy
+446,616
New +$29.3M 0.04% 571
2024
Q3
– Sell
-227,922
Closed -$8.85M – 2295
2024
Q2
$8.85M Buy
+227,922
New +$8.52M 0.02% 656
2023
Q4
– Sell
-270
Closed -$7.47K – 2726
2023
Q3
$7.47K Buy
+270
New +$8.01K ﹤0.01% 2343
2023
Q1
– Sell
-383,339
Closed -$9.13M – 2508
2022
Q4
$9.13M Buy
+383,339
New +$8.15M 0.03% 581
2022
Q3
– Sell
-27,667
Closed -$539K – 1690
2022
Q2
$539K Sell
27,667
-364,431
-93% -$7.09M ﹤0.01% 1169
2022
Q1
$10M Buy
+392,098
New +$8.53M 0.04% 513
2021
Q4
– Sell
-55,000
Closed -$1.51M – 1269
2021
Q3
$1.51M Sell
55,000
-137,600
-71% -$4M 0.01% 813
2021
Q2
$6.11M Buy
+192,600
New +$6.72M 0.03% 570

Other funds holding RVMD

Steven Cohen's RVMD Position: Q3 2026 in Review

Steven Cohen increased its Revolution Medicines (RVMD) stake by 253% in Q3 2026, buying an estimated $30.3M and bringing the position to 212,971 shares worth $43.7M. The position accounts for 0.05% of the portfolio, ranked #511.

Steven Cohen first reported a position in RVMD in Q2 2021 and has held it in 10 quarters since. 749 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Steven Cohen held 212,971 shares of Revolution Medicines worth $43.7M as of Q3 2026.
  • Steven Cohen bought 152,695 Revolution Medicines shares in Q3 2026, an estimated $30.3M.
  • Revolution Medicines made up 0.05% of Steven Cohen's portfolio in Q3 2026, its #511 holding.
  • Steven Cohen first reported a position in Revolution Medicines in Q2 2021 and has held it in 10 quarters since.
  • 749 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.